Works by Ouellet, Daniele

Results: 50

Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 698, doi. 10.1002/cpt.3083

By:

Shahin, Mohamed H.;
Barth, Aline;
Podichetty, Jagdeep T.;
Liu, Qi;
Goyal, Navin;
Jin, Jin Y.;
Ouellet, Daniele

Publication type:

Article

Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 412, doi. 10.1002/cpt.3133

By:

Ait‐Oudhia, Sihem;
Wang, Yow‐Ming;
Dosne, Anne‐Gaelle;
Roy, Amit;
Jin, Jin Y.;
Shen, Jun;
Kagan, Leonid;
Musuamba, Flora T.;
Zhang, Lucia;
Kijima, Shinichi;
Gastonguay, Marc R.;
Ouellet, Daniele

Publication type:

Article

Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1011, doi. 10.1002/cpt.2823

By:

Xu, Zhenhua;
Leu, Jocelyn H.;
Xu, Yan;
Nnane, Ivo;
Liva, Sophia G.;
Wang‐Lin, Shun Xin;
Kudgus‐Lokken, Rachel;
Vermeulen, An;
Ouellet, Daniele

Publication type:

Article

MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 762, doi. 10.1002/cpt.1788

By:

Krishnaswami, Sriram;
Austin, Daren;
Della Pasqua, Oscar;
Gastonguay, Marc R.;
Gobburu, Jogarao;
Graaf, Piet H.;
Ouellet, Daniele;
Tannenbaum, Stacey;
Visser, Sandra A. G.

Publication type:

Article

Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 151, doi. 10.1007/s00280-021-04381-4

By:

Dosne, Anne-Gaëlle;
Valade, Elodie;
Goeyvaerts, Nele;
De Porre, Peter;
Avadhani, Anjali;
O'Hagan, Anne;
Li, Lilian Y.;
Ouellet, Daniele;
Perez Ruixo, Juan Jose

Publication type:

Article

Translational characterization of [<sup>11</sup>C]GSK931145, a PET ligand for the glycine transporter type 1.

Published in:

Synapse, 2011, v. 65, n. 12, p. 1319, doi. 10.1002/syn.20966

By:

Gunn, Roger N.;
Murthy, Venkatesha;
Catafau, Ana M.;
Searle, Graham;
Bullich, Santiago;
Slifstein, Mark;
Ouellet, Daniele;
Zamuner, Stefano;
Herance, Raul;
Salinas, Cristian;
Pardo-Lozano, Ricardo;
Rabiner, Eugenii A.;
Farre, Magi;
Laruelle, Marc

Publication type:

Article

Population pharmacokinetics of trabectedin in adolescent patients with cancer.

Published in:

2019

By:

Poggesi, Italo;
Valenzuela, Belén;
Ouellet, Daniele;
Gonzalez, Martha;
Hillewaert, Vera;
Baruchel, Sylvain;
Fox, Elizabeth;
Perez-Ruixo, Juan Jose

Publication type:

journal article

Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumors.

Published in:

2019

By:

Valade, Elodie;
Dosne, Anne-Gaëlle;
Xie, Hong;
Kleiman, Robert;
Li, Lilian Y.;
Perez-Ruixo, Juan José;
Ouellet, Daniele

Publication type:

journal article

The pH-altering agent omeprazole affects rate but not the extent of ibrutinib exposure.

Published in:

2018

By:

de Jong, Jan;
Haddish-Berhane, Nahor;
Hellemans, Peter;
Jiao, James;
Sukbuntherng, Juthamas;
Ouellet, Daniele

Publication type:

journal article

Correction to: Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study.

Published in:

2018

By:

de Jong, Jan;
Hellemans, Peter;
Jiao, James Juhui;
Huang, Yuhan;
Mesens, Sofie;
Sukbuntherng, Juthamas;
Ouellet, Daniele

Publication type:

journal article

Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study.

Published in:

2017

By:

de Jong, Jan;
Hellemans, Peter;
Jiao, James;
Huang, Yuhan;
Mesens, Sofie;
Sukbuntherng, Juthamas;
Ouellet, Daniele;
Jiao, James Juhui

Publication type:

journal article

Population pharmacokinetics and exposure-response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma.

Published in:

2016

By:

Ouellet, Daniele;
Kassir, Nastya;
Chiu, Joannellyn;
Mouksassi, Mohamad-Samer;
Leonowens, Cathrine;
Cox, Donna;
DeMarini, Douglas;
Gardner, Olivia;
Crist, Wendy;
Patel, Kiran;
DeMarini, Douglas J

Publication type:

journal article

Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1507, doi. 10.1007/s00280-013-2150-9

By:

Hayes, Siobhan;
Mudd, Paul;
Ouellet, Daniele;
Johnson, Brendan;
Williams, Daphne;
Gibiansky, Ekaterina

Publication type:

Article

Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.

Published in:

Pharmacology Research & Perspectives, 2020, v. 8, n. 5, p. 1, doi. 10.1002/prp2.649

By:

de Jong, Jan;
Mitselos, Anna;
Jurczak, Wojciech;
Cordoba, Raul;
Panizo, Carlos;
Wrobel, Tomasz;
Dlugosz-Danecka, Monika;
Jiao, James;
Sukbuntherng, Juthamas;
Ouellet, Daniele;
Hellemans, Peter

Publication type:

Article

A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 2888, doi. 10.1080/10428194.2018.1460474

By:

de Jong, Jan;
Hellemans, Peter;
De Wilde, Severijn;
Patricia, Daniel;
Masterson, Tara;
Manikhas, Georgii;
Myasnikov, Alexander;
Osmanov, Dzhelil;
Córdoba, Raúl;
Panizo, Carlos;
de Zwart, Loeckie;
Snoeys, Jan;
Chauhan, Vijay;
Jiao, James;
Sukbuntherng, Juthamas;
Ouellet, Daniele

Publication type:

Article

Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

Published in:

Targeted Oncology, 2024, v. 19, n. 6, p. 965, doi. 10.1007/s11523-024-01093-6

By:

Willemin, Marie-Emilie;
Gong, Jue;
Hilder, Brandi W.;
Masterson, Tara;
Tolbert, Jaszianne;
Renaud, Thomas;
Heuck, Christoph;
Kane, Colleen;
De Zwart, Loeckie;
Girgis, Suzette;
Ma, Xuewen;
Ouellet, Daniele

Publication type:

Article

Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 667, doi. 10.1007/s11523-023-00989-z

By:

Miao, Xin;
Wu, Liviawati S.;
Lin, Shun Xin Wang;
Xu, Yan;
Chen, Yang;
Iwaki, Yuki;
Kobos, Rachel;
Stephenson, Tara;
Kemmerer, Kristy;
Uhlar, Clarissa M.;
Banerjee, Arnob;
Goldberg, Jenna D.;
Trancucci, Danielle;
Apte, Amit;
Verona, Raluca;
Pei, Lixia;
Desai, Rachit;
Hickey, Kathleen;
Su, Yaming;
Ouellet, Daniele

Publication type:

Article

Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.

Published in:

2024

By:

Bonate, Peter L.;
Barrett, Jeffrey S.;
Ait-Oudhia, Sihem;
Brundage, Richard;
Corrigan, Brian;
Duffull, Stephen;
Gastonguay, Marc;
Karlsson, Mats O.;
Kijima, Shinichi;
Krause, Andreas;
Lovern, Mark;
Riggs, Matthew M.;
Neely, Michael;
Ouellet, Daniele;
Plan, Elodie L.;
Rao, Gauri G.;
Standing, Joseph;
Wilkins, Justin;
Zhu, Hao

Publication type:

Correction Notice

Training the next generation of pharmacometric modelers: a multisector perspective.

Published in:

2024

By:

Bonate, Peter L.;
Barrett, Jeffrey S.;
Ait-Oudhia, Sihem;
Brundage, Richard;
Corrigan, Brian;
Duffull, Stephen;
Gastonguay, Marc;
Karlsson, Mats O.;
Kijima, Shinichi;
Krause, Andreas;
Lovern, Mark;
Riggs, Matthew M.;
Neely, Michael;
Ouellet, Daniele;
Plan, Elodie L.;
Rao, Gauri G.;
Standing, Joseph;
Wilkins, Justin;
Zhu, Hao

Publication type:

Letter

Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 2, p. 133, doi. 10.1007/s10928-022-09841-9

By:

Hu, Chuanpu;
Vetter, Marion;
Vermeulen, An;
Ouellet, Daniele

Publication type:

Article

Optimization of clinical dosing schedule to manage neutropenia: learnings from semi-mechanistic modeling simulation approach.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 1, p. 47, doi. 10.1007/s10928-019-09667-y

By:

Guo, Yue;
Haddish-Berhane, Nahor;
Xie, Hong;
Ouellet, Daniele

Publication type:

Article

The American Conference on Pharmacometrics 2016 (ACoP7).

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2016, v. 43, p. 1, doi. 10.1007/s10928-016-9488-7

By:

Ouellet, Daniele;
Trame, Mirjam;
Corrigan, Brian

Publication type:

Article

Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 524, doi. 10.1111/bcp.12373

By:

Leonowens, Cathrine;
Pendry, Carolyn;
Bauman, John;
Young, Graeme C.;
Ho, May;
Henriquez, Frank;
Fang, Lei;
Morrison, Royce A.;
Orford, Keith;
Ouellet, Daniele

Publication type:

Article

Modeling Sleep Data for a New Drug in Development using Markov Mixed-Effects Models.

Published in:

Pharmaceutical Research, 2011, v. 28, n. 10, p. 2610, doi. 10.1007/s11095-011-0490-x

By:

Kjellsson, Maria;
Ouellet, Daniele;
Corrigan, Brian;
Karlsson, Mats

Publication type:

Article

Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 511, doi. 10.1007/s40262-023-01340-5

By:

Yu, Alex;
Hazra, Anasuya;
Jiao, James Juhui;
Hellemans, Peter;
Mitselos, Anna;
Tian, Hui;
Ruixo, Juan Jose Perez;
Haddish-Berhane, Nahor;
Ouellet, Daniele;
Russu, Alberto

Publication type:

Article

Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model.

Published in:

Clinical Pharmacokinetics, 2020, v. 59, n. 9, p. 1149, doi. 10.1007/s40262-020-00881-3

By:

Van den Bergh, An;
Snoeys, Jan;
De Zwart, Loeckie;
Ward, Peter;
Lopez-Gitlitz, Angela;
Ouellet, Daniele;
Monshouwer, Mario;
Chien, Caly

Publication type:

Article

Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.

Published in:

2020

By:

Pérez-Ruixo, Carlos;
Pérez-Blanco, Jonás Samuel;
Chien, Caly;
Yu, Margaret;
Ouellet, Daniele;
Pérez-Ruixo, Juan-José;
Ackaert, Oliver

Publication type:

journal article

Teclistamab: Mechanism of action, clinical, and translational science.

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13717

By:

Guo, Yue;
Quijano Cardé, Natalia A.;
Kang, Lijuan;
Verona, Raluca;
Banerjee, Arnob;
Kobos, Rachel;
Chastain, Katherine;
Uhlar, Clarissa;
Pillarisetti, Kodandaram;
Doyle, Margaret;
Smit, Jennifer;
Haddish‐Berhane, Nahor;
Ouellet, Daniele

Publication type:

Article

Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit.

Published in:

British Journal of Clinical Pharmacology, 2009, v. 68, n. 2, p. 174, doi. 10.1111/j.1365-2125.2009.03444.x

By:

Corrigan, Brian;
Feltner, Douglas E.;
Ouellet, Daniele;
Werth, John L.;
Moton, Allen E.;
Gibson, Gordon

Publication type:

Article

Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 6, p. 741, doi. 10.1111/j.1365-2125.2006.02589.x

By:

Ouellet, Daniele;
Bramson, Candace;
Carvajal-Gonzalez, Santos;
Roman, Doina;
Randinitis, Edward;
Remmers, Ann;
Gardner, Mark J.

Publication type:

Article

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.

Published in:

British Journal of Clinical Pharmacology, 1998, v. 46, n. 2, p. 111, doi. 10.1046/j.1365-2125.1998.00749.x

By:

Ouellet, Daniele;
Hsu, Ann;
Qian, Jiang;
Locke, Charles S.;
Eason, Carolyn J.;
Cavanaugh, John H.;
Leonard, John M.;
Granneman, G. Richard

Publication type:

Article

Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 10, p. 977, doi. 10.1080/17512433.2023.2257136

By:

Niu, Jin;
Wang, Weirong;
Ouellet, Daniele

Publication type:

Article

A Single-Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 1, p. 29, doi. 10.1177/0091270005283278

By:

Bramson, Candace;
Ouellet, Daniele;
Roman, Doina;
Randinitis, Edward;
Gardner, Mark J.

Publication type:

Article

Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women.

Published in:

Journal of Clinical Pharmacology, 2005, v. 45, n. 12, p. 1407, doi. 10.1177/0091270005282627

By:

Roman, Doina;
Bramson, Candace;
Ouellet, Daniele;
Randinitis, Edward;
Gardner, Mark

Publication type:

Article

Pharmacokinetics of Quinapril in Children: Assessment during Substitution for Chronic Angiotensin-Converting Enzyme Inhibitor Treatment.

Published in:

Journal of Clinical Pharmacology, 2003, v. 43, n. 2, p. 128, doi. 10.1177/0091270002239820

By:

Blumer, Jeffrey L.;
Daniels, Stephen R.;
Dreyer, William J.;
Batisky, Donald;
Walson, Philip D.;
Roman, Doina;
Ouellet, Daniele

Publication type:

Article

Single-Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children.

Published in:

Journal of Clinical Pharmacology, 2001, v. 41, n. 5, p. 507, doi. 10.1177/00912700122010384

By:

Haig, George M.;
Bockbrader, Howard N.;
Wesche, David L.;
Boellner, Samuel W.;
Ouellet, Daniele;
Brown, Richard R.;
Randinitis, Edward J.;
Posvar, Edward L.

Publication type:

Article

Pharmacokinetic interaction between ritonavir and clarithromycin<sup>*</sup>.

Published in:

Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 355, doi. 10.1016/S0009-9236(98)90065-0

By:

Ouellet, Danièle;
Hsu, Ann;
Granneman, G. Richard;
Carlson, Glenn;
Cavanaugh, John;
Guenther, Helen;
Leonard, John M.

Publication type:

Article

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1117, doi. 10.1002/psp4.13144

By:

Willemin, Marie‐Emilie;
Wang Lin, Shun Xin;
De Zwart, Loeckie;
Wu, Liviawati S.;
Miao, Xin;
Verona, Raluca;
Banerjee, Arnob;
Liu, Baolian;
Kobos, Rachel;
Qi, Ming;
Ouellet, Daniele;
Goldberg, Jenna D.;
Girgis, Suzette

Publication type:

Article

Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 5, p. 569, doi. 10.1002/psp4.12727

By:

Dosne, Anne‐Gaëlle;
Valade, Elodie;
Stuyckens, Kim;
De Porre, Peter;
Avadhani, Anjali;
O'Hagan, Anne;
Li, Lilian Y.;
Ouellet, Daniele;
Faelens, Ruben;
Leirens, Quentin;
Poggesi, Italo;
Perez Ruixo, Juan Jose

Publication type:

Article

Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 8, p. 435, doi. 10.1002/psp4.12537

By:

Hughes, Jim H.;
Sweeney, Kevin;
Ahadieh, Sima;
Ouellet, Daniele

Publication type:

Article

Population Pharmacokinetics of Total and Free Erdafitinib in Adult Healthy Volunteers and Cancer Patients: Analysis of Phase 1 and Phase 2 Studies.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, n. 4, p. 515, doi. 10.1002/jcph.1547

By:

Dosne, Anne‐Gaelle;
Valade, Elodie;
Stuyckens, Kim;
Li, Lilian Y.;
Ouellet, Daniele;
Perez‐Ruixo, Juan Jose

Publication type:

Article

Effect of Plasma Protein Binding on the Pharmacokinetics of Erdafitinib: Results of an Integrated Cross‐Study Analysis.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, n. 3, p. 391, doi. 10.1002/jcph.1529

By:

Li, Lilian Y.;
Guo, Yue;
Gonzalez, Martha;
Ouellet, Daniele

Publication type:

Article

Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 4, p. 392, doi. 10.1002/jcph.437

By:

Suttle, A. Benjamin;
Grossmann, Kenneth F.;
Ouellet, Daniele;
Richards‐Peterson, Lauren E.;
Aktan, Gursel;
Gordon, Michael S.;
LoRusso, Patricia M.;
Infante, Jeffrey R.;
Sharma, Sunil;
Kendra, Kari;
Patel, Manish;
Pant, Shubham;
Arkenau, Hendrik‐Tobias;
Middleton, Mark R.;
Blackman, Samuel C.;
Botbyl, Jeff;
Carson, Stanley W.

Publication type:

Article

Population pharmacokinetics of dabrafenib, a BRAF inhibitor: Effect of dose, time, covariates, and relationship with its metabolites.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 6, p. 696, doi. 10.1002/jcph.263

By:

Ouellet, Daniele;
Gibiansky, Ekaterina;
Leonowens, Cathrine;
O'Hagan, Anne;
Haney, Patricia;
Switzky, Julie;
Goodman, Vicki L.

Publication type:

Article

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation-Positive Solid Tumors.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 9, p. 955, doi. 10.1002/jcph.127

By:

Denton, Cathrine L.;
Minthorn, Elisabeth;
Carson, Stanley W.;
Young, Graeme C.;
Richards‐Peterson, Lauren E.;
Botbyl, Jeffrey;
Han, Chao;
Morrison, Royce A.;
Blackman, Samuel C.;
Ouellet, Daniele

Publication type:

Article

Evaluation of the Effects of Food on the Single-Dose Pharmacokinetics of Trametinib, a First-in-Class MEK Inhibitor, in Patients with Cancer.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 9, p. 946, doi. 10.1002/jcph.115

By:

Cox, Donna S.;
Papadopoulos, Kyri;
Fang, Lei;
Bauman, John;
LoRusso, Patricia;
Tolcher, Anthony;
Patnaik, Amita;
Pendry, Carolyn;
Orford, Keith;
Ouellet, Daniele

Publication type:

Article

Population PK/PD Modeling of Eltrombopag in Healthy Volunteers and Patients With Immune Thrombocytopenic Purpura and Optimization of Response-Guided Dosing.

Published in:

Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1403, doi. 10.1177/0091270010383019

By:

Hayes, Siobhan;
Ouellet, Daniele;
Zhang, Jianping;
Wire, Mary B.;
Gibiansky, Ekaterina

Publication type:

Article

Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura.

Published in:

Journal of Clinical Pharmacology, 2011, v. 51, n. 6, p. 842, doi. 10.1177/0091270010375427

By:

Gibiansky, Ekaterina;
Zhang, Jianping;
Williams, Daphne;
Wang, Zhao;
Ouellet, Daniele

Publication type:

Article

Exposure-Response Analyses of the Effects of Pregabalin in Patients With Fibromyalgia Using Daily Pain Scores and Patient Global Impression of Change.

Published in:

Journal of Clinical Pharmacology, 2010, v. 50, n. 7, p. 803, doi. 10.1177/0091270009352187

By:

Wonkyung Byon;
Ouellet, Daniele;
Chew, Marci;
Ito, Kaori;
Burger, Paula;
Pauer, Lynne;
Zeiher, Bernhardt;
Corrigan, Brian

Publication type:

Article

Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators.

Published in:

Statistics in Biopharmaceutical Research, 2023, v. 15, n. 3, p. 697, doi. 10.1080/19466315.2023.2166099

By:

Marchenko, Olga;
Sridhara, Rajeshwari;
Jiang, Qi;
Barksdale, Elizabeth;
Ando, Yuki;
Alwis, Dinesh De;
Brown, Katie;
Fernandes, Laura;
van Bussel, Mark T. J.;
Choo, Qiuyi;
Coory, Michael;
Garrett-Mayer, Elizabeth;
Gwise, Thomas;
Hess, Lorenzo;
Liu, Rong;
Mandrekar, Sumithra;
Ouellet, Daniele;
Pinheiro, José;
Posch, Martin;
Rahman, Nam Atiqur

Publication type:

Article